Logo image of HSDT

SOLANA CO (HSDT) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:HSDT - US42328V8761 - Common Stock

4.15 USD
+0.14 (+3.49%)
Last: 11/28/2025, 4:57:08 PM
4.2383 USD
+0.09 (+2.13%)
After Hours: 11/28/2025, 4:57:08 PM
Fundamental Rating

3

Overall HSDT gets a fundamental rating of 3 out of 10. We evaluated HSDT against 188 industry peers in the Health Care Equipment & Supplies industry. No worries on liquidiy or solvency for HSDT as it has an excellent financial health rating, but there are worries on the profitability. HSDT is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

HSDT had negative earnings in the past year.
HSDT had a negative operating cash flow in the past year.
HSDT had negative earnings in each of the past 5 years.
In the past 5 years HSDT always reported negative operating cash flow.
HSDT Yearly Net Income VS EBIT VS OCF VS FCFHSDT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -5M -10M -15M -20M -25M

1.2 Ratios

HSDT has a Return On Assets of -269.67%. This is amonst the worse of the industry: HSDT underperforms 94.68% of its industry peers.
The Return On Equity of HSDT (-353.22%) is worse than 77.13% of its industry peers.
Industry RankSector Rank
ROA -269.67%
ROE -353.22%
ROIC N/A
ROA(3y)-175.99%
ROA(5y)-174.45%
ROE(3y)-552.67%
ROE(5y)-436.83%
ROIC(3y)N/A
ROIC(5y)N/A
HSDT Yearly ROA, ROE, ROICHSDT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20K -20K

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for HSDT so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
HSDT Yearly Profit, Operating, Gross MarginsHSDT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -2K -4K

More info and screens

8

2. Health

2.1 Basic Checks

HSDT does not have a ROIC to compare to the WACC, probably because it is not profitable.
HSDT has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, HSDT has more shares outstanding
There is no outstanding debt for HSDT. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
HSDT Yearly Shares OutstandingHSDT Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2K 4K 6K 8K
HSDT Yearly Total Debt VS Total AssetsHSDT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M

2.2 Solvency

An Altman-Z score of 15.23 indicates that HSDT is not in any danger for bankruptcy at the moment.
HSDT has a better Altman-Z score (15.23) than 91.49% of its industry peers.
HSDT has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 15.23
ROIC/WACCN/A
WACC8.64%
HSDT Yearly LT Debt VS Equity VS FCFHSDT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M -20M

2.3 Liquidity

A Current Ratio of 4.32 indicates that HSDT has no problem at all paying its short term obligations.
HSDT's Current ratio of 4.32 is fine compared to the rest of the industry. HSDT outperforms 74.47% of its industry peers.
HSDT has a Quick Ratio of 3.69. This indicates that HSDT is financially healthy and has no problem in meeting its short term obligations.
HSDT has a better Quick ratio (3.69) than 75.00% of its industry peers.
Industry RankSector Rank
Current Ratio 4.32
Quick Ratio 3.69
HSDT Yearly Current Assets VS Current LiabilitesHSDT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M

More info and screens

4

3. Growth

3.1 Past

The Earnings Per Share has been growing slightly by 6.54% over the past year.
HSDT shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -19.25%.
The Revenue for HSDT have been decreasing by -19.09% on average. This is quite bad
EPS 1Y (TTM)6.54%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%102.81%
Revenue 1Y (TTM)-19.25%
Revenue growth 3Y0%
Revenue growth 5Y-19.09%
Sales Q2Q%1266.67%

3.2 Future

HSDT is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 40.27% yearly.
The Revenue is expected to grow by 177.16% on average over the next years. This is a very strong growth
EPS Next Y87.29%
EPS Next 2Y40.27%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-20.09%
Revenue Next 2Y18.3%
Revenue Next 3Y346.25%
Revenue Next 5Y177.16%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
HSDT Yearly Revenue VS EstimatesHSDT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 20M 40M 60M 80M
HSDT Yearly EPS VS EstimatesHSDT Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 -50K -100K -150K -200K -250K

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

HSDT reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for HSDT. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
HSDT Price Earnings VS Forward Price EarningsHSDT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
HSDT Per share dataHSDT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -200 -400 -600 -800 -1K

4.3 Compensation for Growth

A more expensive valuation may be justified as HSDT's earnings are expected to grow with 40.27% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y40.27%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

HSDT does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

SOLANA CO

NASDAQ:HSDT (11/28/2025, 4:57:08 PM)

After market: 4.2383 +0.09 (+2.13%)

4.15

+0.14 (+3.49%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)11-18 2025-11-18/amc
Earnings (Next)03-23 2026-03-23/amc
Inst Owners1.11%
Inst Owner Change1548.05%
Ins Owners0%
Ins Owner Change0%
Market Cap171.40M
Revenue(TTM)520.00K
Net Income(TTM)-21.29M
Analysts43.33
Price TargetN/A
Short Float %2.35%
Short Ratio0.53
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)26.48%
Min EPS beat(2)13.79%
Max EPS beat(2)39.17%
EPS beat(4)3
Avg EPS beat(4)13.75%
Min EPS beat(4)-6.38%
Max EPS beat(4)39.17%
EPS beat(8)6
Avg EPS beat(8)15.45%
EPS beat(12)9
Avg EPS beat(12)20.9%
EPS beat(16)12
Avg EPS beat(16)16.5%
Revenue beat(2)0
Avg Revenue beat(2)-47.88%
Min Revenue beat(2)-51.96%
Max Revenue beat(2)-43.79%
Revenue beat(4)1
Avg Revenue beat(4)-28.35%
Min Revenue beat(4)-66.67%
Max Revenue beat(4)49.02%
Revenue beat(8)3
Avg Revenue beat(8)-24.88%
Revenue beat(12)6
Avg Revenue beat(12)-16.96%
Revenue beat(16)9
Avg Revenue beat(16)-4.5%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 581
P/FCF N/A
P/OCF N/A
P/B 28.44
P/tB 28.44
EV/EBITDA N/A
EPS(TTM)-1206.39
EYN/A
EPS(NY)-65.79
Fwd EYN/A
FCF(TTM)-0.28
FCFYN/A
OCF(TTM)-0.28
OCFYN/A
SpS0.01
BVpS0.15
TBVpS0.15
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -269.67%
ROE -353.22%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-175.99%
ROA(5y)-174.45%
ROE(3y)-552.67%
ROE(5y)-436.83%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0.04
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 0%
Cap/Sales 0%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 4.32
Quick Ratio 3.69
Altman-Z 15.23
F-Score3
WACC8.64%
ROIC/WACCN/A
Cap/Depr(3y)10.97%
Cap/Depr(5y)13.37%
Cap/Sales(3y)2.54%
Cap/Sales(5y)5.95%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)6.54%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%102.81%
EPS Next Y87.29%
EPS Next 2Y40.27%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-19.25%
Revenue growth 3Y0%
Revenue growth 5Y-19.09%
Sales Q2Q%1266.67%
Revenue Next Year-20.09%
Revenue Next 2Y18.3%
Revenue Next 3Y346.25%
Revenue Next 5Y177.16%
EBIT growth 1Y-21.67%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-5.75%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-6%
OCF growth 3YN/A
OCF growth 5YN/A

SOLANA CO / HSDT FAQ

What is the fundamental rating for HSDT stock?

ChartMill assigns a fundamental rating of 3 / 10 to HSDT.


Can you provide the valuation status for SOLANA CO?

ChartMill assigns a valuation rating of 1 / 10 to SOLANA CO (HSDT). This can be considered as Overvalued.


How profitable is SOLANA CO (HSDT) stock?

SOLANA CO (HSDT) has a profitability rating of 0 / 10.


Can you provide the financial health for HSDT stock?

The financial health rating of SOLANA CO (HSDT) is 8 / 10.